Sharenet Sites 
Sharenet Sites
Trading statement – Audited group results for the year ended 31 March 2014
MEDICLINIC INTERNATIONAL LIMITED
(Incorporated in the Republic of South Africa)
(Registration number: 1983/010725/06)
(Share code: MDC)
(ISIN: ZAE000074142)
("Mediclinic" or "the Company")
TRADING STATEMENT – AUDITED GROUP RESULTS FOR THE YEAR ENDED
31 MARCH 2014
In terms of the JSE Limited ("JSE") Listings Requirements,
companies are required to publish a trading statement as soon as
they are satisfied that a reasonable degree of certainty exists
that the financial results for the period to be reported upon next
will differ by at least 20% from that of the previous
corresponding reporting period. Mediclinic is in the process of
finalising its year-end results for the twelve months ended 31
March 2014, which are due to be released on SENS on 21 May 2014
and published in the press on 22 May 2014 ("year-end results
announcement").
Accordingly, shareholders are advised that the Company’s basic
earnings per share ("EPS") and basic headline earnings per share
("HEPS") for the year ended 31 March 2014 are expected to be
between 375% and 385% higher than the restated results reported
for the previous corresponding reporting period as released on
SENS on 6 November 2013 ("the EPS and HEPS range").
In order to provide clear and meaningful guidance to shareholders,
this trading statement will also address normalised HEPS.
Normalised HEPS are defined as reportable HEPS in terms of
accounting standards, excluding one-off items.
The one-off items are included in calculating the EPS and HEPS
range and relate mainly to past service costs for the current
financial year. Details of one-off items will be provided in the
year-end results announcement. Excluding the one-off items, the
basic normalised HEPS for the year ended 31 March 2014 are
expected to be between 40% and 50% higher than the restated basic
normalised HEPS reported for the previous corresponding reporting
period as released on SENS on 6 November 2013.
The financial information on which this trading statement is based
has not been reviewed and reported on by the Company’s external
auditors.
Stellenbosch
6 May 2014
Mediclinic Offices, Strand Road, Stellenbosch 7600, South Africa
PO Box 456, Stellenbosch 7599, South Africa
Tel +27 21 809 6500
Fax +27 21 886 4037
Ethics line: 0800 005 316
Website: www.mediclinic.com
Sponsor
RAND MERCHANT BANK (A division of FirstRand Bank Limited)
Date: 06/05/2014 01:25:00 Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE').
The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of
the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct,
indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on,
information disseminated through SENS.
